Schedule 13D - Activist Investments
NASDAQ
Gang Lai, CEO and Chairman of Universe Pharmaceuticals, has increased his beneficial ownership to 13.58% through direct holdings and a controlled entity, following an equity grant.
Schedule 13G - Passive Investments
See all →NASDAQ
Star Voyage International Limited and Xuncheng Chen report a combined beneficial ownership of 9.94% in Universe Pharmaceuticals INC's Class A ordinary shares.
NASDAQ
August Luck Global Limited and Xuefeng Li now collectively beneficially own 9.29% of Universe Pharmaceuticals INC's Class A ordinary shares.
NASDAQ
Meridian Prosperous Limited and Shanshan Lu have filed a Schedule 13G, reporting beneficial ownership of 498,922 Class A ordinary shares, representing 9.96% of Universe Pharmaceuticals INC.
NASDAQ
Horizon Ridge Limited and Shan Xie have jointly filed a Schedule 13G, reporting beneficial ownership of 9.97% of Universe Pharmaceuticals INC's Class A ordinary shares.
NASDAQ
Origin Force Intelligence Limited and Piao Ye have entered into a joint filing agreement to report beneficial ownership of Universe Pharmaceuticals INC Class A ordinary shares.
NASDAQ
Clever Way Global Limited and Lu Yang have jointly filed a Schedule 13G, reporting beneficial ownership of 9.96% of Universe Pharmaceuticals INC's Class A ordinary shares.